Every healthcare professional has the responsibility to use the latest tech innovations available to fight diseases. Artificial intelligence can sometimes exceed human expertise by unveiling unseen meaning out of huge amounts of data. At Keen Eye, we strive to make that deeper meaning available to every physician, biologist, and patient. Our partners depend on the information in bio- and medical images to advance scientific research, to shorten drug development timeline and to improve diagnostic accuracy for better patient care. They come to Keen Eye for tools to improve their productivity and outcome, and to uncover insights and meanings out of huge amounts of data. Learn more here about how Keen Eye’s team of data scientists create AI-powered applications to give them a competitive edge to get ahead.Introducing the most advanced image-centric platform for pathologists and translational scientists. More than a digital pathology workflow management system, the Keen Eye Platform™ enables researchers to run AI applications on tissue images; either alone or integrated with other molecular biomarkers.
Total Funding: €7.5 M
Funding Stage: Series A
Business Stage: Scaling Up
Market: B2B
Company Size: 26 to 50
Founded: 2015
For AI Startup Founders
Get introduced to VC/PE/CVC investors
For Investors at VC/PE firms
Get introduced to AI Startup founders or founders at Keen Eye Technologies
Backend Software Engineer
Paris, Paris
Business Developer Intern
Paris, Paris
Senior Cloud Sysadmin
Paris, Paris
Keen Eye Technologies - AI Startup | AI Startup Profile Powered by Appengine AI | Appengine AI - AI Ecosystem of 12,000+ AI Startups
Keen Eye Technologies - Manage Profile